That is, these reports suggest that indicated the neuroprotective effect of orexin-A was not only involved in the improvement of post-ischemic glucose intolerance, but also other factors (including other neuroprotective mechanisms such as enhances the cerebral blood flow and inhibits ischemic stress-induced increment of HIF-1α). Here, HIF1A is linked to Glucose intolerance.